Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Paull Radu"'
Autor:
Linda Levi, Daisy Zamora, Igor Nastas, Ilan Gonen, Paull Radu, Valentin Matei, Adela M. Ciobanu, Anatol Nacu, Larisa Boronin, Lusian Karakrah, Michael Davidson, John M. Davis, Mark Weiser
Publikováno v:
The Journal of clinical psychiatry. 83(5)
Autor:
Michael H. Davidson, Ilan Gonen, Paull Radu, Igor Nastas, Linda Levi, Daisy Zamora, Mark Weiser, John M. Davis, Valentin Petre Matei, Anatol Nacu, Larisa Boronin
Publikováno v:
Schizophr Bull
Two previous randomized controlled trials (RCTs) suggested that adjunctive aspirin is efficacious in treating schizophrenia. We conducted two 16-week double-blind randomized placebo-controlled RCTs of adjunctive 1000 mg aspirin vs placebo in schizoph
Autor:
Valentin Petre Matei, Daisy Zamora, Linda Levi, Michael Davidson, Mark Weiser, Paull Radu, John M. Davis, Ilan Gonen
Publikováno v:
Schizophrenia Bulletin Open. 1
One previous small single-center clinical trial showed that a single intravenous administration of sodium nitroprusside added-on to antipsychotics improved a wide spectrum of schizophrenia (SCZ) symptoms more than placebo, and the improvement persist
Autor:
René S Kahn, Inge Winter van Rossum, Stefan Leucht, Philip McGuire, Shon W Lewis, Marion Leboyer, Celso Arango, Paola Dazzan, Richard Drake, Stephan Heres, Covadonga M Díaz-Caneja, Dan Rujescu, Mark Weiser, Silvana Galderisi, Birte Glenthøj, Marinus J C Eijkemans, W Wolfgang Fleischhacker, Shitij Kapur, Iris E Sommer, Inge Winter-van Rossum, Metten Somers, Paula C Ywema, Shitisj Kapur, Andreas Meyer-Lindenberg, Wolfgang W Fleischhacker, Anne Lotte Meijering, Jocelyn Petter, Resy Van de Brug, Joost Schotsman, Jildou Zwerver, Jos Peuskens, Marc De Hert, Erik Thys, Lucho G Hranov, Valentin Hranov, Jan Libiger, Richard Köhler, Pavel Mohr, Birte Glenthoj, Brian Broberg, Signe Düring, Lone Baandrup, Stephane Jamain, Ina Giegling, Mor Bar Heim, Michael Davidson, Paola Bucci, Armida Mucci, Janusz Rybakowski, Agnieszka Remlinger-Molenda, Ilan Gonen, Paull Radu, Marina Díaz-Marsá, Alberto Rodriguez, Tomas Palomo, Roberto Rodriguez-Jimenez, Paz García-Portilla, Miquel Bernardo, Julio Bobes, Christina Vilares Oliveira, Gregor Berger, Claudia Wildt, Roccio Perez-Iglesias, Sarah Gregory, Danielle Wilson
Publikováno v:
The Lancet Psychiatry, 5(10), 797. Elsevier Limited
McGuire, P & Dazzan, P 2018, ' Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE) : a three-phase switching study ', The lancet. Psychiatry, vol. 5, no. 10, pp. 797-807 . https://doi.org/10.1016/S2215-0366(18)30252-9
The Lancet. Psychiatry, 5(10), 797-807. ELSEVIER SCI LTD
McGuire, P & Dazzan, P 2018, ' Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE) : a three-phase switching study ', The lancet. Psychiatry, vol. 5, no. 10, pp. 797-807 . https://doi.org/10.1016/S2215-0366(18)30252-9
The Lancet. Psychiatry, 5(10), 797-807. ELSEVIER SCI LTD
BACKGROUND: No established treatment algorithm exists for patients with schizophrenia. Whether switching antipsychotics or early use of clozapine improves outcome in (first-episode) schizophrenia is unknown.METHODS: This three-phase study was done in
Autor:
Paull Radu, Shimon Burshtein, Ilan Gonen, John M. Davis, Mark Weiser, Linda Levi, Kristina Slobozean Pavalache, Michael Davidson, Timothy J. Ryan, Igor Nastas, John Paul SanGiovanni, Anat Biegon, Daisy Zamora, Rina Hemi
Publikováno v:
JAMA Psychiatry
IMPORTANCE: Several lines of evidence suggest that estradiol influences the course of schizophrenia, and a previous randomized controlled trial demonstrated that transdermal estradiol improved symptoms in female patients of childbearing age. However,
Autor:
Paull Radu, Nadav Orr, Marcia K. Wolf, David E. Katz, Zivit Klein, Thomas L. Hale, Tamar Halperin, Raid Kayouf, Ruhama Ambar, M. Yavzori, Malabi M. Venkatesan, Tamar Sela, Dani Cohen, Jacob Atsmon
Publikováno v:
Infection and immunity. 73(12)
We describe the first community-based evaluation of Shigella sonnei strain WRSS1, a live, oral candidate vaccine attenuated by a 212-bp deletion in the virG (or icsA ) plasmid virulence gene. Three single-dose regimens of WRSS1 (5 × 10 3 CFU, 2 × 1